Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, CCR7 | 4 | 2025 | 19 | 1.150 |
Why?
|
| Chemokines, CC | 1 | 2022 | 55 | 0.710 |
Why?
|
| Type C Phospholipases | 1 | 2020 | 23 | 0.630 |
Why?
|
| Chemokine CCL19 | 2 | 2025 | 10 | 0.450 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1723 | 0.320 |
Why?
|
| Adaptive Immunity | 1 | 2025 | 34 | 0.230 |
Why?
|
| Chemotaxis | 2 | 2024 | 68 | 0.230 |
Why?
|
| Immunity, Humoral | 1 | 2025 | 29 | 0.230 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 9 | 0.220 |
Why?
|
| Hepadnaviridae | 1 | 2004 | 1 | 0.220 |
Why?
|
| Virus Integration | 1 | 2004 | 65 | 0.210 |
Why?
|
| T-Lymphocytes | 1 | 2025 | 386 | 0.190 |
Why?
|
| DNA, Viral | 1 | 2004 | 311 | 0.190 |
Why?
|
| Lymph Nodes | 1 | 2022 | 74 | 0.180 |
Why?
|
| Cell Physiological Phenomena | 1 | 2020 | 9 | 0.160 |
Why?
|
| Biological Products | 1 | 2021 | 91 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2021 | 195 | 0.150 |
Why?
|
| Lead Poisoning, Nervous System, Childhood | 1 | 2019 | 9 | 0.150 |
Why?
|
| Isoenzymes | 1 | 2020 | 168 | 0.150 |
Why?
|
| Organometallic Compounds | 1 | 2019 | 71 | 0.150 |
Why?
|
| Microglia | 1 | 2019 | 208 | 0.130 |
Why?
|
| Signal Transduction | 1 | 2025 | 2157 | 0.120 |
Why?
|
| Hippocampus | 1 | 2019 | 594 | 0.120 |
Why?
|
| Humans | 4 | 2024 | 43102 | 0.080 |
Why?
|
| Animals | 6 | 2025 | 16992 | 0.080 |
Why?
|
| Female | 3 | 2025 | 24698 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 1869 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 2676 | 0.060 |
Why?
|
| Chemokine CCL21 | 1 | 2024 | 14 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2004 | 15 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2025 | 259 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 68 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2004 | 148 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 294 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2004 | 119 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 209 | 0.050 |
Why?
|
| Mice | 2 | 2025 | 6644 | 0.050 |
Why?
|
| Plasmids | 1 | 2004 | 244 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2024 | 152 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2024 | 290 | 0.050 |
Why?
|
| Transfection | 1 | 2004 | 532 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 455 | 0.050 |
Why?
|
| Chickens | 1 | 2004 | 161 | 0.050 |
Why?
|
| DNA Repair | 1 | 2004 | 198 | 0.050 |
Why?
|
| Base Sequence | 1 | 2004 | 983 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2025 | 1035 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 163 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 224 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 61 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 655 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 259 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 31 | 0.040 |
Why?
|
| Lactation | 1 | 2019 | 44 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2019 | 352 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 456 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1604 | 0.030 |
Why?
|
| Macrophages | 1 | 2019 | 529 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1857 | 0.030 |
Why?
|
| CHO Cells | 1 | 2004 | 123 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 241 | 0.010 |
Why?
|
| Male | 1 | 2019 | 23409 | 0.010 |
Why?
|